93 related articles for article (PubMed ID: 2802258)
21. Effect of methylprednisolone on coagulation.
Pandit HB; Spillert CR
J Natl Med Assoc; 1999 Aug; 91(8):453-6. PubMed ID: 12656434
[TBL] [Abstract][Full Text] [Related]
22. An assessment of monocyte procoagulant activity in patients with solid tumors.
Dasmahapatra KS; Cheung NK; Spillert C; Lazaro E
J Surg Res; 1987 Aug; 43(2):158-63. PubMed ID: 3626537
[TBL] [Abstract][Full Text] [Related]
23. Haemostatic derangement in advanced peripheral occlusive arterial disease.
Koksch M; Zeiger F; Wittig K; Pfeiffer D; Ruehlmann C
Int Angiol; 1999 Dec; 18(4):256-62. PubMed ID: 10811512
[TBL] [Abstract][Full Text] [Related]
24. Blood fluidity and coagulation phenomena in chronic arterial occlusive disease.
Angelkort B; Boateng K; Maurin N
J Int Med Res; 1980; 8(3):242-6. PubMed ID: 7389992
[TBL] [Abstract][Full Text] [Related]
25. Coagulation effects of cyclosporine in liver transplantation.
Ferrante RJ; Spillert CR; Wilson DJ; Lazaro EJ
Agents Actions; 1993; 39 Spec No():C102-3. PubMed ID: 8273541
[TBL] [Abstract][Full Text] [Related]
26. In vitro effect of activated recombinant factor VII (rFVIIa) on coagulation properties of human blood at hypothermic temperatures.
Kheirabadi BS; Delgado AV; Dubick MA; Scherer MR; Fedyk CG; Holcomb JB; Pusateri AE
J Trauma; 2007 Nov; 63(5):1079-86. PubMed ID: 17993954
[TBL] [Abstract][Full Text] [Related]
27. Monocyte tissue factor expression, cell activation, and thrombin formation during cardiopulmonary bypass: a clinical study.
Ernofsson M; Thelin S; Siegbahn A
J Thorac Cardiovasc Surg; 1997 Mar; 113(3):576-84. PubMed ID: 9081105
[TBL] [Abstract][Full Text] [Related]
28. Tissue factor, tissue pathway factor inhibitor and risk factors of atherosclerosis in patients with chronic limbs ischemia: preliminary study.
Gosk-Bierska I; Wysokin Ski W; Karnicki K; Adamiec R
Int Angiol; 2008 Aug; 27(4):296-301. PubMed ID: 18677291
[TBL] [Abstract][Full Text] [Related]
29. Tissue thromboplastin generation in circulating mononuclear phagocytes and development of coagulation disorders during E. coli endotoxinaemia in pigs.
Andersen OK; Osterud B; Gaudernack G; Lundgren TI; Giercksky KE
Acta Chir Scand; 1985; 151(3):205-11. PubMed ID: 3925666
[TBL] [Abstract][Full Text] [Related]
30. Monocyte procoagulant activity as a peripheral marker of clotting activation in cancer patients.
Morgan D; Edwards RL; Rickles FR
Haemostasis; 1988; 18(1):55-65. PubMed ID: 3047024
[TBL] [Abstract][Full Text] [Related]
31. The use of dielectric blood coagulometry in the evaluation of coagulability in patients with peripheral arterial disease.
Igari K; Kudo T; Toyofuku T; Inoue Y
BMC Clin Pathol; 2017; 17():14. PubMed ID: 28852324
[TBL] [Abstract][Full Text] [Related]
32. [Change of tissue factor pathway ratio during attack in patients with acute myocardial infarction and its clinical significance].
Wang R; Wen BZ; Ma YT; Peng -; Li H; Zhong D; Li L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):198-202. PubMed ID: 19236778
[TBL] [Abstract][Full Text] [Related]
33. Determination of hypercoagulable state in acute bronchospasm.
Pandit HB; Spillert CR; Shih RD
J Am Osteopath Assoc; 1999 Apr; 99(4):203-6. PubMed ID: 10327804
[TBL] [Abstract][Full Text] [Related]
34. Compound 48/80 suppresses monocytic tissue factor-initiated extrinsic blood coagulation induced by bacterial endotoxin.
Chu AJ; Raphael UO; Prasad JK; Beydoun S; Ramos N
J Surg Res; 1999 Dec; 87(2):252-7. PubMed ID: 10600357
[TBL] [Abstract][Full Text] [Related]
35. Short-time rabbit model of endotoxin-induced hypercoagulability.
Scherer RU; Giebler RM; Schmidt U; Paar D; Wüst T; Spangenberg P; Militzer K; Hirche H; Kox WJ
Lab Anim Sci; 1995 Oct; 45(5):538-46. PubMed ID: 8569153
[TBL] [Abstract][Full Text] [Related]
36. Blood coagulation unaffected by ozonated autohemotherapy in patients on maintenance hemodialysis.
Biedunkiewicz B; Lizakowski S; Tylicki L; Skiboeska A; Nieweglowski T; Chamienia A; Debska-Slizien A; Rutkowski B
Arch Med Res; 2006 Nov; 37(8):1034-7. PubMed ID: 17045123
[TBL] [Abstract][Full Text] [Related]
37. [Assay methods and their significance of factors involved in tissue factor-dependent coagulation reaction].
Miyata T; Kato H
Rinsho Ketsueki; 1997 Apr; 38(4):319-22. PubMed ID: 9146061
[No Abstract] [Full Text] [Related]
38. Blood coagulation in patients with benign and malignant tumours before and after surgery. Special reference to thromboplastin generation in monocytes.
Osterud B; Due J
Scand J Haematol; 1984 Mar; 32(3):258-64. PubMed ID: 6199833
[TBL] [Abstract][Full Text] [Related]
39. Cold-induced hypercoagulability in vitro: a trauma connection?
Ferraro FJ; Spillert CR; Swan KG; Lazaro EJ
Am Surg; 1992 Jun; 58(6):355-7. PubMed ID: 1596036
[TBL] [Abstract][Full Text] [Related]
40. Relation of haemostatic, fibrinolytic, and rheological variables to the angiographic extent of peripheral arterial occlusive disease.
Woodburn KR; Lowe GD; Rumley A; Love J; Pollock JG
Int Angiol; 1995 Sep; 14(3):219-25. PubMed ID: 8919237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
